午夜一级毛片-手机看片99-动漫人物桶机免费动漫app-日日摸日日碰夜夜97|www.zyjlr.com

TEL:020-31701980      FAX:020-31701979     E-mail:sales@mx008.com
China Mingxuan
Service Hotline:020-3171980
搜索

News
MX trends
industry trends
fair information
 
Micro-channel
 
Information details You are here:Home >> News >> industry trends
 
90% of the products are listed as the lowest in shanxi?
 
Author:中國銘鉉 企劃部  Release Time:2017-8-16 11:07:26  Number Browse:666
 
On August 16, the medical network recently, a paragraph about the drug price, in the medical circle heat up. 
 
"How much is the big brother?" 
 
"360 yuan" 
 
"It's too expensive! Can it be cheap?" 
 
"Yes! 
 
"How much? 
 
"The finer the rope is, the cheaper it is, and the ten dollars are free, free," he said. 
 
Therefore, when you are pursuing effect, you must respect the price!! 
 
Good quality and little money, 
 
Isn't that terrible? 
 
-- to experts who are bidding at low prices 
 
▍ price cut cut again 
 
On the road to squeezing the price of drugs, it is a loop that is increasingly stringent. For many drug companies, every round of drug tendering is a hurdle. It's hard to get through. 
 
According to day wind securities research report, by the middle of July, 2017, zhejiang, anhui, hunan, fujian, guangxi, tianjin, hebei, Inner Mongolia, heilongjiang, sichuan, Beijing and other 11 provinces and cities has already completed a new round of provincial drug centralized purchasing, the national drug prices net has been coming. 
 
Recently, shanxi YaoXie procurement platform released the public medical institutions in Shanxi Province drugs classified purchasing bargaining catalogue of drug centralized bidding results and netting, deployment from August 15 to open a new round of purchasing drug classification. Classification in the process of purchasing, according to the bidding companies, "double envelope evaluation" were taken respectively and according to the national lowest price negotiation, first determine the 1282 bid rules, the overall decline of 17.36%, has reached 90% of the products in the price or lower than the national lowest price execution at the provincial level. 
 
In the belt purchase, up and down linkage, left and right linkage, second bargaining, two-ticket system... This ring buckle one ring of the combination of the fist, the drug company wants to be "iron cock" do not reduce point price? No way! 
 
▍ excessive bargaining problems 
 
The deficiency of drug price is a problem that reform must solve at present, and it is also a strong voice of the common people. However, a special commodity, if overpaid, will also cause serious problems. 
 
1. Poor quality 
 
This goes back to the beginning of this article, how low is the price, but what about quality assurance? 
 
Previously, wu zhen, deputy chief of the state food and drug supervision and administration bureau told reporters, "if we pursue low price, to be honest, low price, there is no good medicine, the quality of the drug is unlikely to be that good." 
 
"Reversed transmission", refers to the low bid only because the drug bidding rules principle, lead to a vicious competition, manufacturing enterprises on the price at a low price won the bid, after used false way of production and profit. 
 
For example, in the case of the CWB, the prevailing low - priced variety shows a worrying quality. For each 4-5 cent of a normal raw material cost, it is hard to imagine that there are only 4 to 5 cents per tablet in some provinces. Even if the cost of promotion is not considered, do enterprises need to produce and transport costs? How can such a winning price guarantee quality? This is also an important reason for the frequent occurrence of the non-conformity list published by the pharmaceutical supervision department. 
 
2. "drug shortage" 
 
In recent years, the shortage of low-cost life-saving medicines has not been isolated. According to incomplete statistics, there are more than 300 kinds of medicines in shortage. 
 
In 2011, there was a nationwide shortage of "heart-cure" fish sperm protein, which could not be completed in clinical heart surgery. Until now, fish sperm protein has often been in short supply or even broken up. 
 
Since July 2013, specializes in treating first overbearing disease of clinical drug he thiazole shortage cities over the country, for the treatment of skin allergy chlorpheniramine maleate, antiphlogistic medicine norfloxacin on the shortage of medicine list. 
 
In May 2015, there was a nationwide shortage of "dioxin tablets" for heart disease. 
 
In August 2015, there appeared many online search for actinomycin D. "If you can't find this medicine, the patient will die." 
 
In September 2016, a nationwide recall of the drug resulted in a number of patients suffering from panic attacks that were not available. During the period of the serious shortage of the tablets of brompyrix, someone said that in order to survive, a bottle of medicine for about 30 yuan would have to be bought for hundreds of times the price of a thousand times the price. 
 
...... 
 
Examples abound. The causes of drug shortages are complex, but we have to admit that the drug shortage has a lot to do with the price of drugs. 
 
Yin yongmei, a professor of oncology at the people's hospital of jiangsu province, said in a media interview that "there are people who make money and there is no production of people who don't make money. Many drugs are priced more than a decade ago, apparently not in line with today's market. 
 
In the face of rising costs, the price of all kinds of cheap medicine can not rise, and it is necessary to go through the bidding and killing price to reduce the price. Or the drug factory is shoddy, racking its brains to think of other ways to squeeze costs. 
 
Either way, the drug companies were injured, or the hospital "drug shortage", but ultimately the victim was still patients. 

 
Previous article:Sichuan province, check medical equipment! No, no!
Next article:Another 124 drug withdrawal! Remove the standard product, the whole country no longer supply
 
Log in  Website Map All right reserved by China Mingxuan, Guangzhou ICP #16026227
    

粵公網(wǎng)安備 44011202000029號